Product Information
Pemigatinib is a potent inhibitor of FGFR2 kinase, which is an enzyme involved in the cell signaling pathways that regulate cell growth and differentiation. Pemigatinib has been shown to inhibit the growth of cancer cells in vitro and in animal models. It also inhibits the proliferation of myeloid leukemia cells by inhibiting the MAPK/ERK and PI3K/AKT signaling pathways, as well as cancer-associated fibroblasts. Pemigatinib has been shown to have activity against infectious diseases such as hepatitis C virus (HCV) infection, with inhibition of HCV replication in vitro. The drug also induces apoptosis in cholangiocarcinoma cells by inhibiting protein synthesis.
Pemigatinib is metabolized through a number of metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase,
Chemical properties
Technical inquiry about: 3D-NKC85777 Pemigatinib (INCB054828)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
